• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
VCNX

VCNX

Vaccinex, Inc.

OTCHealthcareBiotechnologyUS

USD0.77

-0.07 (-8.33%)

Company Profile

CEO

Maurice Zauderer

IPO Date

2018-08-09

Sector

Healthcare

Industry

Biotechnology

Exchange

OTC

Country

US

Market Metrics

Open

$0.76

Prev. Close

$0.84

Day Low

$0.76

Day High

$0.77

52W Low

$0.31

52W High

$1.50

Market Cap

$0.00B

Volume

0.00M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

61.7%

Avg Negative

1.7%

Avg Neutral

36.6%

News Feed

Vaccinex Announces Activation of Clinical Sites to Enroll Patients in Studies of Pepinemab as Single Agent in Alzheimer's Disease and in Combination with KEYTRUDA® in Advanced, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

GlobeNewsWire·6/8/2021·↑ positive

Vaccinex Reports First Quarter 2021 Financial Results and Provides Corporate Update

GlobeNewsWire·5/17/2021·↑ positive

Vaccinex Reports Fourth Quarter 2020 Financial Results and Provides Corporate Update

GlobeNewsWire·3/16/2021·↑ positive

VCNX Stock Price Increased Over 18% Intraday: Why It Happened

Pulse2·2/22/2021·↑ positive

Why Novavax, Vaccinex, Evolus Are Trading Higher Today

Benzinga·2/19/2021·↑ positive

Vaccinex stock soars 223% on partnership deals using its antibody discovery platform (VCNX)

Business Insider·2/19/2021·↑ positive

Vaccinex's stock soars toward record gain on record volume after deals with 'prominent' drug makers

Market Watch·2/19/2021·↑ positive

VCNX Stock: 11 Things to Know About Vaccinex and the Deals That Have Shares Soaring

InvestorPlace·2/19/2021·↑ positive

Why Vaccinex Shares Are Rallying

Benzinga·2/19/2021·↑ positive

VCNX Stock Price Increases Over 60% Pre-Market: Why It Happened

Pulse2·2/19/2021·↓ negative